ABSTRACT
Acute single dose administration of lanthanum chloride (250 mg/kg body wt, ip) to chicks have been found to alter the levels of enzymes of the antioxidant defence system of chick renal cortex fractions. Such changes involved significant decrease in activities of glucose-6-phosphate dehydrogenase, glutathione reductase, glutathione peroxidase and catalase of kidney epithelial cells. However glutathione-S-transferase activity was not altered. Glutathione and total thiol contents were decreased while lipoperoxidative reactions in kidney-cortex was significantly enhanced. The data indicate that amelioration of lanthanum toxicity condition by methionine supplementation may be due to the methionine serving as a precursor of glutathione.
Subject(s)
Animals , Antidotes/pharmacology , Catalase/metabolism , Chickens , Glucosephosphate Dehydrogenase/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Kidney Cortex/drug effects , Lanthanum/toxicity , Male , Methionine/pharmacologyABSTRACT
Oral administration of K2Cr2O7 to male albino rats at an acute dose of 1500 mg/kg body wt/day for 3 days brought about sharp decrease in the activities of glucose-6-phosphate dehydrogenase and glutathione reductase of kidney epithelial cells. The scavenging system of kidney epithelium is also affected as evident by the highly significant fall in the activities of glutathione peroxidase, superoxide dismutase and catalase which ultimately leads to the increase in lipid peroxidation value in kidney cortical homogenate. However, glutathione-s-transferase activity in cytosol and glutathione and total thiol content in cortical homogenate were not altered. Chronic oral administration of K2Cr2O7 (300 mg/kg body wt/day) for 30 days to rats lead to elevation in the activities of glutathione peroxidase, glutathione reductase, glutathione-s-transferase, superoxide dismutase and catalase with no change in glucose-6-phosphate dehydrogenase activity in epithelial cells. This might lead to the increase in glutathione and total thiol status and decrease in lipid peroxidation value in whole homogenate system.
Subject(s)
Animals , Glucosephosphate Dehydrogenase/metabolism , Glutathione/metabolism , Kidney Cortex/drug effects , Lipid Peroxidation/drug effects , Male , Peroxidases/metabolism , Potassium Dichromate/pharmacology , RatsABSTRACT
Acute lanthanum chloride (250 mg/kg body wt) and neodymium chloride (200 mg/kg body wt) administrations resulted in significant enhancement of glutathione level in chick hepatic mitochondria. However, glutathione-s-transferase activity was depressed. There was no alteration in the activity of glutathione reductase. Activity of glucose-6-phosphate dehydrogenase was not altered under lanthanum and neodymium treatment. There was a significant enhancement of intramitochondrial glutathione peroxidase and superoxide dismutase. Lipid peroxidation remains the same as control group of animals.
Subject(s)
Animals , Antioxidants/metabolism , Chickens , Lanthanum/pharmacology , Male , Mitochondria, Liver/drug effects , Neodymium/pharmacologyABSTRACT
Acute single dose (ip) administration of two rare earth elements like lanthanum chloride (250 mg/kg body wt) and neodymium chloride (200 mg/kg body wt) to chicks have been found to reduce the activity of certain erythrocyte membrane bound enzymes, viz. acetylcholinesterase, NADH dehydrogenase, Mg(2+)-ATPase, p-nitrophenyl phosphatase. Erythrocyte membrane bound glycosidases e.g. beta-D-glucosidase, beta-D-galactosidase and beta-D-glucuronidase were also reduced. Other components such as cholesterol and phospholipid residues were reduced but their ratio (cholesterol/phospholipid) remaining unchanged. Membrane sulfhydryl groups were also significantly inhibited by these rare earth elements.
Subject(s)
Animals , Chickens , Erythrocyte Membrane/drug effects , Glycoside Hydrolases/blood , Lanthanum/toxicity , Male , Membrane Lipids/blood , Neodymium/toxicityABSTRACT
Acute oral administration of K2Cr2O7 (1500 mg/kg body wt/day) for 3 days to rats led to the decrease in activities of glucose-6-phosphate dehydrogenase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, superoxide dismutase and catalase of intestinal epithelial cells. Glutathione and total thiol contents were decreased while lipid peroxidation was increased markedly using the whole homogenate of the intestinal epithelial cells. Chronic oral administration of K2Cr2O7 (300 mg/kg body wt/day) for 30 days to rats on the other hand, led to marked increase in superoxide dismutase and glutathione peroxidase activities with no appreciable change in glucose-6-phosphate dehydrogenase, glutathione reductase and catalase activities. However, glutathione-S-transferase activity was decreased significantly. In the whole homogenate of rat intestine, glutathione and total thiol contents were decreased not so significantly but there was a slight enhancement in lipid peroxidation value.
Subject(s)
Animals , Chromium/pharmacology , Epithelial Cells , Epithelium/drug effects , Glutathione/metabolism , Intestines/cytology , Male , RatsABSTRACT
Retinoic acid (RA) was found to inhibit ADP induced but not collagen induced aggregation of human platelets and the differential action is related to intraplatelet Ca2+ reflux. RA was active at concentrations as low as 10(-7) M and required 20 min prior incubation with platelet suspension in order to inhibit aggregation by ADP. All the steps in ADP induced but not collagen induced platelet activation, viz. hydrolysis of phosphatidyl inositol, phosphorylation of 20, 47 and 250 kDa proteins as well as increased association of actin with Triton X-100 insoluble cytoskeletal matrix were inhibited by RA. RA when used as an agent for differentiation induction of cell progenitor is likely to affect the platelet aggregation and thereby the haemostatic process.
Subject(s)
Adenosine Diphosphate/pharmacology , Blood Platelets/drug effects , Calcium/blood , Collagen/pharmacology , Humans , Male , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/pharmacology , Tretinoin/pharmacologyABSTRACT
Treatment with cadmium chloride (40mg/kg body wt/day) for three days led to a marked inhibition of Mg2(+)-ATPase activity in rat liver nuclear membrane, whereas it stimulated the enzyme in renal nuclear membrane. On 30 days treatment (15 mg/kg body wt/day) the effect was totally different i.e. stimulation of enzyme activity in the liver and inhibition in the kidney tissue. Arrhenius plot analysis of the enzyme activity showed significant increase in phase transition temperature only in liver tissue of rats subjected to acute treatment. Lineweaver Burk plots also showed differential effect of cadmium toxicity on the enzyme activity, i.e. while both Km and Vmax were changed in the liver, there was change only in Km of enzyme from kidney.
Subject(s)
Animals , Ca(2+) Mg(2+)-ATPase/metabolism , Cadmium/toxicity , Cadmium Chloride , Kidney/drug effects , Liver/drug effects , Male , Nuclear Envelope/enzymology , Organ Specificity , RatsABSTRACT
Collagen stimulation of blood platelets resulted in significant increases in malondialdehyde (MDA) formation and activity of glucose-6-phosphate dehydrogenase (G6PDH) and a decrease in catalase and glutathione peroxidase (GPx). Retinoic acid (RA) pretreatment did not show any appreciable changes except for a decrease in G6PDH activity as compared with collagen alone. RA pretreatment of human blood platelets resulted in an increase in the activities of catalase and GPx, two important radical scavenging enzymes, with significant decrease in MDA formation when compared with ADP alone. It is suggested that RA has a significant effect on the antioxidant defence system in ADP stimulated platelets but not in the collagen stimulated platelets.
Subject(s)
Adenosine Diphosphate/pharmacology , Blood Platelets/enzymology , Catalase/metabolism , Collagen/pharmacology , Glucosephosphate Dehydrogenase/metabolism , Glutathione Peroxidase/metabolism , Glutathione Transferase/metabolism , Humans , Malondialdehyde/metabolism , Peroxidases/metabolism , Platelet Activation , Tretinoin/pharmacologyABSTRACT
Arylsulphatases A, B and C were found to be inhibited in liver and kidney tissues under lead acetate-treated conditions (both in vivo and in vitro) in rats. When lead acetate-treated animals (in vivo) were supplemented with ferric ammonium citrate (in vivo), a remarkable recovery was found in the activities of all arylsulphatases A, B and C whereas ferric ammonium citrate itself had no effect on the activities of arylsulphatases. When both the in vivo and in vitro lead acetate-treated arylsulphatases were supplemented with the purified ferritins (in vitro) it was observed that lead-induced inhibition of the activities of arylsulphatases was successfully reversed. It was also found that ferritins were able to bind a large quantity of lead. These results indicated that ferritins were directly involved for reactivation of arylsulphatases which were inhibited by lead. It was well established that a response to iron administration in rats was an immediate de novo stimulation of ferritin biosynthesis. Iron might therefore protect the enzymatic activities of arylsulphatases by enhancing the level of ferritin in liver and kidney tissues which is known to bind a large quantity of lead thereby ameliorating their toxic effects in the living system.
Subject(s)
Animals , Arylsulfatases/metabolism , Iron/physiology , Kidney/drug effects , Liver/drug effects , Male , Organometallic Compounds/toxicity , Rats , Sulfatases/metabolismABSTRACT
Effects of cadmium treatment on human platelets were studied with respect to uptake and release of 5-[3H]hydroxytryptamine (5-HT). The uptake of 5-[3H]HT in the presence of varying concentrations of CdCl2 (0.001-10 mM) was inhibited significantly with respect to control platelets and the inhibition was maximum at 1 mM CdCl2 concentration. From studies on the kinetics of 5-[3H]HT uptake a higher Km and significantly lower Vmax for CdCl2-treated platelets were observed. CdCl2 stimulated spontaneous release but inhibited thrombin-induced release of 5-[3H]HT. Spontaneous release of 5-[3H]HT induced by CdCl2 was not significantly altered in the presence of externally available CaCl2 (1 mM).
Subject(s)
Blood Platelets/drug effects , Cadmium/pharmacology , Humans , Serotonin/blood , Thrombin/pharmacologyABSTRACT
Uptake of Cd by human RBC in vitro was studied. The uptake was found to be biphasic with a rapid initial phase followed by a slower second phase which was still increasing at the time of the last experiment (60 min). Both the phases were found to be independent of metabolically derived energy and unaffected by zinc in the incubation medium.